UroGen Pharma
URGN
#6931
Rank
NZ$0.79 B
Marketcap
$18.80
Share price
-0.65%
Change (1 day)
-18.36%
Change (1 year)

UroGen Pharma (URGN) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.44 Billion

According to UroGen Pharma's latest financial reports the company has NZ$0.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

UroGen Pharma - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.21 B37.56%
2022-12-31NZ$0.15 B20.65%
2021-12-31NZ$0.13 B-7.7%
2020-12-31NZ$0.14 B-35.26%
2019-12-31NZ$0.21 B44.58%
2018-12-31NZ$0.15 B46.95%
2017-12-31NZ$0.10 B233.3%
2016-12-31NZ$30.83 M17.42%
2015-12-31NZ$26.26 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B 9.13%๐Ÿ‡บ๐Ÿ‡ธ USA